Trial Condition(s):

Therapeutic Equivalency, Biological Availability, Postmenopause

Study to investigate the bioequivalence and bioavailability of different formulations containing 0.030 mg Ethinylestradiol and 0.125 mg Levonorgestrel in postmenopausal women

Bayer Identifier:

91340

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
39
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Minisiston/Monostep (EE30/LNG, BAY86-4977)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design